rituximab Archives - No Health Problems News

Rituximab, mycophenolate mofetil compared for pemphigus vulgaris

05/19/2021 Health News

(HealthDay)—For patients with pemphigus vulgaris, rituximab is superior to mycophenolate mofetil for producing sustained complete remission at 52 weeks, according […]

» Read more

mofet, mycophenolate, rituximab

Antiangiogenic Agents for Cancer May Boost Aneurysm Risk

04/03/2021 Health News

NEW YORK (Reuters Health) – Caution may be required when using anticancer drugs targeting angiogenesis because of the potential risk […]

» Read more

adverse events in pharmacology, aneurysm, angiogenesis, angiogenesis inhibitor, anti-cancer agents, antiangiogenesis, antineoplastic drug, bevacizumab, cancer, Carcinoma, erlotinib, gefitinib, imatinib, inhibitor (angiogenesis), malignant neoplasia, malignant neoplasm, oncological medicine, patient safety, rituximab, su11248, sunitinib, trastuzumab, vegf (vascular endothelial growth factor)